2Mc Nally M A，J Bone Joint Surg（Am），1997年，79卷，1198页
3Mc Nally M A，J R Coll Surg Edinb，1997年，42卷，407页
4Hui A C，J Bone Joint Surg（Br），1996年，78卷，550页
5Planes A，J Bone Joint Surg（Br），1990年，72卷，9页
6Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 2004, 126(3 Suppl): 338-400.
7Anderson FA Jr, Spencer FA. Risk factors for venous thromboembolism. Circulation, 2003, 107(23 Suppl 1): 9-16.
8Liew NC, Moissinac K, Gul Y. Postoperative venous thromboembolism in Asia: a critical appraisal of its incidence. Asian J Surg,2003, 26: 154-158.
9Geerts WH, Heir JA, Clagett GP, et al. Prevention of venous thromboembolism. Chest, 2001, 119(1 Suppl): 132-175.
10Turpie AG, Bauer KA, Eriksson BI, et al. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. Arch Intern Med, 2002, 162: 1833-1840.
8Van Balen R, Steyerberg EW, Polder JJ, et al. Hip fracture in elderly patients Outcomes for function, quality of life, and type of residence[J]. Clinical orthopaedics and related research, 2001, 390(9): 232-243.
9Shyu YL, Chen MC, Liang J, et al. Predictors of functional recovery for hip fractured elders during 12 months followlng hospital discharge: a prospective study on a Taiwan Residents sample [J]. Osteoporos Int, 2004(15):475-482.
